Sustained Improvement Over 52 Weeks in Patient-Reported Itch, Symptoms, and Quality of Life With Upadacitinib in Patients With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2023）
关键词
atopic dermatitis,upadacitinib,itch,sustained improvement,patient-reported
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要